Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Focan

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
British Journal of Cancer|April 21, 2005
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatinX M Li, K Tanaka, J Sun, et al.
Revue Medicale De Liege|October 15, 1977
[Sequential chemotherapy aimed at the synchronization-recruitment and circadian rhythm of solid tumors in the adult: theoretical bases and results of a randomised trial]C Focan, S Le Hung, M Derouaux, et al.
Bulletin Du Cancer|January 1, 1984
[Efficacy of sequential chemotherapy including vincristine, cisplatin and ifosfamide in the treatment of stage IV head and neck carcinomas and melanomas with visceral involvement. Preliminary results]C Focan, E Salamon, S Le Hung, et al.
Anti-Cancer Drugs|August 1, 1991
Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methodsR Rahmani, X J Zhou, P Boré, et al.
Revue Medicale De Liege|April 1, 1993
[Hepatic angiosarcoma in a patient with autoimmune hepatitis]M A Reginster, V Mazy, D Waltregny, et al.
Pathologie-Biologie|April 10, 2007
[Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers]C Focan, F Kreutz, L Longrée, et al.
Pathologie-Biologie|October 30, 2012
Phase I - II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 studyC Focan, F Kreutz, M-P Graas, et al.
Tumori|June 11, 1999
Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of CancerC Garufi, L Dogliotti, E Terzoli, et al.
Pathologie-Biologie|June 9, 2005
[Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer]C Focan, F Kreutz, M P Graas, et al.
Revue Medicale De Liege|May 8, 2009
[Esthesioneuroblastoma: a case report and literature review]L Kalala, C Focan, F Schils, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
British Journal of Cancer|April 21, 2005
Preclinical relevance of dosing time for the therapeutic index of gemcitabine-cisplatinX M Li, K Tanaka, J Sun, et al.
Revue Medicale De Liege|October 15, 1977
[Sequential chemotherapy aimed at the synchronization-recruitment and circadian rhythm of solid tumors in the adult: theoretical bases and results of a randomised trial]C Focan, S Le Hung, M Derouaux, et al.
Bulletin Du Cancer|January 1, 1984
[Efficacy of sequential chemotherapy including vincristine, cisplatin and ifosfamide in the treatment of stage IV head and neck carcinomas and melanomas with visceral involvement. Preliminary results]C Focan, E Salamon, S Le Hung, et al.
Anti-Cancer Drugs|August 1, 1991
Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methodsR Rahmani, X J Zhou, P Boré, et al.
Revue Medicale De Liege|April 1, 1993
[Hepatic angiosarcoma in a patient with autoimmune hepatitis]M A Reginster, V Mazy, D Waltregny, et al.
Pathologie-Biologie|April 10, 2007
[Interest of chronotherapy in multidisciplinary management of oesophageal and gastric cancers]C Focan, F Kreutz, L Longrée, et al.
Pathologie-Biologie|October 30, 2012
Phase I - II study to assess the feasibility and activity of the triple combination of 5-fluorouracil/folinic acid, carboplatin and irinotecan (CPT-11) administered by chronomodulated infusion for the treatment of advanced colorectal cancer. Final report of the BE-1603 studyC Focan, F Kreutz, M-P Graas, et al.
Tumori|June 11, 1999
Tumori. Chronotherapy Study Group of the European Organization for Research and Treatment of CancerC Garufi, L Dogliotti, E Terzoli, et al.
Pathologie-Biologie|June 9, 2005
[Feasibility survey (Phase I-II) of a four drugs combination (5-fluorouracil, folinic acid, carboplatin and irinotecan) delivered using a chronomodulated infusion in the treatment of advanced colorectal cancer]C Focan, F Kreutz, M P Graas, et al.
Revue Medicale De Liege|May 8, 2009
[Esthesioneuroblastoma: a case report and literature review]L Kalala, C Focan, F Schils, et al.
Pageof 15